mesalamine has been researched along with Lymph Node Metastasis in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Excerpt | Relevance | Reference |
---|---|---|
"The use of immunosuppressants for the treatment of nephrotic syndrome might affect the development of rectal carcinoma." | 1.43 | Ulcerative colitis associated with nephrotic syndrome after treatment with mesalazine developed into rectal carcinoma: a case study. ( Koketsu, S; Kubota, Y; Noie, T; Okuyama, T; Ono, Y; Oya, M; Sameshima, S, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sameshima, S | 1 |
Koketsu, S | 1 |
Okuyama, T | 1 |
Kubota, Y | 1 |
Ono, Y | 1 |
Noie, T | 1 |
Oya, M | 1 |
1 other study available for mesalamine and Lymph Node Metastasis
Article | Year |
---|---|
Ulcerative colitis associated with nephrotic syndrome after treatment with mesalazine developed into rectal carcinoma: a case study.
Topics: Adenocarcinoma; Adolescent; Antineoplastic Agents; Colitis, Ulcerative; Colonoscopy; Humans; Lymphat | 2016 |